SCHEMBL1425072

SCHEMBL1425072

Cc1cc(C(N)=O)cc(CO)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 1/20 0.43
▸ POLB P06746 1/20 0.41
▸ IKBKB O14920 2/20 0.40
▸ PARP1 P09874 1/20 0.40
▸ BRD4 O60885 2/20 0.39
▸ CYP1A2 P05177 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ KDM4E B2RXH2 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MEN1 O00255 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ CHUK O15111 1/20 0.34
▸ PRKACA P17612 1/20 0.34
▸ PRKACG P22612 1/20 0.34
▸ PRKACB P22694 1/20 0.34
▸ LIMK1 P53667 1/20 0.34
▸ BTK Q06187 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1425022 0.85 HTT (0.43) HTTPOLBIKBKBPARP1BRD4
SCHEMBL17490722 0.84 HTT (0.42) HTTPOLBIKBKBPARP1BRD4
SCHEMBL1425060 0.83 TPMT (0.48) HTTTSHRKMT2AKDM4EMAPK1
SCHEMBL1179736 0.82 POLB (0.50) HTTPOLBIKBKBPARP1CYP1A2
Hydrochloric Acid SCHEMBL1425309 0.81 TPMT (0.47) HTTTSHRKMT2AKDM4EMAPK1
SCHEMBL30295698 0.79 ALDH1A1 (0.49) POLBTSHRKMT2AKDM4ELMNA
SCHEMBL1425020 0.79 ALDH1A1 (0.49) POLBTSHRKMT2AKDM4ELMNA
SCHEMBL30578988 0.78 BRD4 (0.39) HTTPOLBPARP1BRD4TSHR
SCHEMBL27238086 0.78 BRD4 (0.39) HTTPOLBPARP1BRD4TSHR
Benzamide SCHEMBL29088364 0.76 PARP1 (0.57) POLBPARP1BRD4TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8598208-B2 Pyridine derivatives as S1P1/EDG1 receptor modulators ACTELION PHARMACEUTICALS LTD. (CH) 2013-12-03 — — US disclosed
US-20110212998-A1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD. (CH) 2011-09-01 — — US disclosed
EP-2195311-B1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2011-03-23 — — EP disclosed
EP-2195311-A1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS Actelion Pharmaceuticals Ltd. (CH) 2010-06-16 — — EP disclosed
WO-2009024905-A1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS ACTELION PHARMACEUTICALS LTD (CH) 2009-02-26 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212998-A1 PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS S1PR1, S1PR3, S1PR2 HTT 4682/4885POLB 4759/4885IKBKB 1571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback